Gemina Laboratories Ltd. (TSE:GLAB) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Gemina Laboratories Ltd. has successfully raised $435,000 through the exercise of common share purchase warrants and has also settled a $40,000 debt with lenders by issuing 100,000 common shares at a discounted price. The company is known for its innovative biosensor and diagnostic technology, which is currently being developed for rapid testing of various pathogens, including COVID-19 and influenza.
For further insights into TSE:GLAB stock, check out TipRanks’ Stock Analysis page.
